Endothelin and endothelin receptors in the renal and cardiovascular systems

Life Sciences

Volumn 91, Issue 13-14, 2012, Pages 490-500

  Vignon Zellweger, Nicolas ^a   Heiden, Susi ^a   Miyauchi, Takashi ^b   Emoto, Noriaki ^a,c  

^a KOBE PHARMACEUTICAL UNIVERSITY   (Japan)

^b UNIVERSITY OF TSUKUBA   (Japan)

^c KOBE UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Endothelin receptor; Endothelin 1; Heart; Kidney; Molecular biology; Vasculature

Indexed keywords

ADENYLATE CYCLASE; AQUAPORIN 2; ATRASENTAN; BOSENTAN; CALCIUM CALMODULIN DEPENDENT PROTEIN KINASE; CALCIUM CHANNEL L TYPE; DIPEPTIDYL CARBOXYPEPTIDASE; ENDOTHELIAL NITRIC OXIDE SYNTHASE; ENDOTHELIN 1; ENDOTHELIN A RECEPTOR; ENDOTHELIN B RECEPTOR; ENDOTHELIN RECEPTOR ANTAGONIST; HYPOXIA INDUCIBLE FACTOR 1ALPHA; INOSITOL TRISPHOSPHATE; MACITENTAN; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; N (2,6 DIMETHYLPIPERIDINOCARBONYL) 4 METHYLLEUCYL DEXTRO (1 METHOXYCARBONYLTRYPTOPHANYL) DEXTRO NORLEUCINE; PHOSPHOLIPASE C; PROTEIN C FOS; PROTEIN C JUN; PROTEIN KINASE C; REACTIVE OXYGEN METABOLITE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; SARAFOTOXIN S6C; SODIUM CALCIUM EXCHANGE PROTEIN; SODIUM PROTON EXCHANGE PROTEIN; SUCCINYLENDOTHELIN 1 [8-21][9 GLUTAMIC ACID 11,15 ALANINE]; UNINDEXED DRUG;

APOPTOSIS; ATHEROSCLEROSIS; BINDING AFFINITY; BLOOD VESSEL TONE; CALCIUM CELL LEVEL; CARDIOVASCULAR DISEASE; CELL INFILTRATION; CELL PROLIFERATION; CONFERENCE PAPER; DIABETIC NEPHROPATHY; DISEASE COURSE; ENDOTHELIUM CELL; ENZYME INHIBITION; FIBROBLAST; GENE OVEREXPRESSION; GENETIC TRANSCRIPTION; GLOMERULUS FILTRATION RATE; HEART FAILURE; HEART MUSCLE CELL; HEART MUSCLE CONTRACTILITY; HEART PROTECTION; HEART VENTRICLE HYPERTROPHY; HENLE LOOP; HUMAN; IMMUNOPRECIPITATION; INOTROPISM; INTERNALIZATION; INTRACELLULAR SIGNALING; KIDNEY COLLECTING TUBULE; KIDNEY DISEASE; KIDNEY TUBULE DISORDER; KIDNEY VASCULAR RESISTANCE; NONHUMAN; OXIDATIVE STRESS; PATHOPHYSIOLOGY; PROTEIN EXPRESSION; PULMONARY HYPERTENSION; RECEPTOR BINDING; RENOVASCULAR HYPERTENSION; SMOOTH MUSCLE FIBER; SODIUM ABSORPTION; SYSTEMIC VASCULAR RESISTANCE; UNSPECIFIED SIDE EFFECT; VASOCONSTRICTION; WATER ABSORPTION;

ANIMALS; CARDIOVASCULAR DISEASES; CARDIOVASCULAR SYSTEM; ENDOTHELIN-1; ENDOTHELINS; HUMANS; KIDNEY; KIDNEY DISEASES; RECEPTOR, ENDOTHELIN A; RECEPTOR, ENDOTHELIN B;

EID: 84867574237     PISSN: 00243205     EISSN: 18790631     Source Type: Journal    
DOI: 10.1016/j.lfs.2012.03.026     Document Type: Conference Paper

References (167)

1. D. Ahn, Y. Ge, P.K. Stricklett, P. Gill, D. Taylor, and A.K. Hughes Collecting duct-specific knockout of endothelin-1 causes hypertension and sodium retention J Clin Invest 114 2004 504 511
2. F. Amiri, A. Virdis, M.F. Neves, M. Iglarz, N.G. Seidah, and R.M. Touyz Endothelium-restricted overexpression of human endothelin-1 causes vascular remodeling and endothelial dysfunction Circulation 110 2004 2233 2240
3. F. Amiri, P. Paradis, T.L. Reudelhuber, and E.L. Schiffrin Vascular inflammation in absence of blood pressure elevation in transgenic murine model overexpressing endothelin-1 in endothelial cells J Hypertens 26 2008 1102 1109
4. I. Anand, J. McMurray, J.N. Cohn, M.A. Konstam, T. Notter, and K. Quitzau Long-term effects of darusentan on left-ventricular remodelling and clinical outcomes in the Endothelin A Receptor Antagonist Trial in Heart Failure (EARTH): randomised, double-blind, placebo-controlled trial Lancet 364 2004 347E 354E
5. D.W. Anggrahini, N. Emoto, K. Nakayama, B. Widyantoro, S. Adiarto, and N. Iwasa Vascular endothelial cell-derived endothelin-1 mediates vascular inflammation and neointima formation following blood flow cessation Cardiovasc Res 82 2009 143 151
6. H. Arai, S. Hori, I. Aramori, H. Ohkubo, and S. Nakanishi Cloning and expression of a cDNA encoding an endothelin receptor Nature 348 1990 730 732
7. A.J. Bagnall, N.F. Kelland, F. Gulliver-Sloan, A.P. Davenport, G.A. Gray, and M. Yanagisawa Deletion of endothelial cell endothelin B receptors does not affect blood pressure or sensitivity to salt Hypertension 48 2006 286 293
8. M.A. Bailey, C. Haton, V. Orea, J. Sassard, C. Bailly, and R.J. Unwin ETA receptor-mediated Ca2+ signaling in thin descending limbs of Henle's loop: impairment in genetic hypertension Kidney Int 63 2003 1276 1284
9. M. Barton, C.C. Haudenschild, L.V. D'Uscio, S. Shaw, K. Münter, and T.F. Lüscher Endothelin ETA receptor blockade restores NO-mediated endothelial function and inhibits atherosclerosis in apolipoprotein E-deficient mice Proc Natl Acad Sci U S A 95 1998 14367 14372
10. B. Battistini, N. Berthiaume, N.F. Kelland, D.J. Webb, and D.E. Kohan Profile of past and current clinical trials involving endothelin receptor antagonists: the novel -sentan class of drug Exp Biol Med (Maywood) 231 2006 653 695
11. A. Benigni, V. Colosio, C. Brena, I. Bruzzi, T. Bertani, and G. Remuzzi Unselective inhibition of endothelin receptors reduces renal dysfunction in experimental diabetes Diabetes 47 1998 450 456
12. G. Bkaily, R. Naik, P. Orleans-Juste, S. Wang, and C.N. Fong Endothelin-1 activates the R-type Ca2+ channel in vascular smooth-muscle cells J Cardiovasc Pharmacol 26 Suppl. 3 1995 S303 S306
13. M.A. Bogoyevitch, P.E. Glennon, M.B. Andersson, A. Clerk, A. Lazou, and C.J. Marshall Endothelin-1 and fibroblast growth factors stimulate the mitogen-activated protein kinase signaling cascade in cardiac myocytes. The potential role of the cascade in the integration of two signaling pathways leading to myocyte hypertrophy J Biol Chem 269 1994 1110 1119
14. T. Bremnes, J.D. Paasche, A. Mehlum, C. Sandberg, B. Bremnes, and H. Attramadal Regulation and intracellular trafficking pathways of the endothelin receptors J Biol Chem 275 2000 17596 17604
15. V. Bugaj, E. Mironova, D.E. Kohan, and J.D. Stockand Collecting duct-specific endothelin B receptor knockout increases ENaC activity Am J Physiol Cell Physiol 302 1 2012 C188 94 [Jan]
16. G. Calo, J.P. Gratton, S. Telemaque, P. Orleans-Juste, and D. Regoli Pharmacology of endothelins: vascular preparations for studying ETA and ETB receptors Mol Cell Biochem 154 1996 31 37
17. C. Cao, W. Lee-Kwon, E.P. Silldorff, and T.L. Pallone KATP channel conductance of descending vasa recta pericytes Am J Physiol Renal Physiol 289 2005 F1235 F1245
18. A. Chahdi, and A. Sorokin Endothelin-1 induces p66Shc activation through EGF receptor transactivation: role of beta(1)Pix/Galpha(i3) interaction Cell Signal 22 2010 325 329
19. M.Y. Chang, E. Parker, M. El Nahas, J.L. Haylor, and A.C. Ong Endothelin B receptor blockade accelerates disease progression in a murine model of autosomal dominant polycystic kidney disease J Am Soc Nephrol 18 2007 560 569
20. M.C. Chappell, P.E. Gallagher, D.B. Averill, C.M. Ferrario, and K.B. Brosnihan Estrogen or the AT1 antagonist olmesartan reverses the development of profound hypertension in the congenic mRen2. Lewis rat Hypertension 42 2003 781 786
21. H.E. Cingolani, M.C. Villa-abrille, M. Cornelli, A. Nolly, I.L. Ennis, and C.D. Garciarena The positive inotropic effect of angiotensin II: role of endothelin-1 and reactive oxygen species Hypertension 47 2006 727 734
22. A. Clerk, T.J. Kemp, J.G. Harrison, A.J. Mullen, P.J. Barton, and P.H. Sugden Up-regulation of c-jun mRNA in cardiac myocytes requires the extracellular signal-regulated kinase cascade, but c-Jun N-terminal kinases are required for efficient up-regulation of c-Jun protein Biochem J 368 2002 101 110
23. M. Clozel, V. Breu, G.A. Gray, B. Kalina, B.M. Loffler, and K. Burri Pharmacological characterization of bosentan, a new potent orally active nonpeptide endothelin receptor antagonist J Pharmacol Exp Ther 270 1994 228 235
24. F. Collino, B. Bussolati, E. Gerbaudo, L. Marozio, S. Pelissetto, and C. Benedetto Preeclamptic sera induce nephrin shedding from podocytes through endothelin-1 release by endothelial glomerular cells Am J Physiol Renal Physiol 294 2008 F1185 F1194
25. R. Coppo, V. Fonsato, S. Balegno, E. Ricotti, E. Loiacono, and R. Camilla Aberrantly glycosylated IgA1 induces mesangial cells to produce platelet-activating factor that mediates nephrin loss in cultured podocytes Kidney Int 77 2010 417 427
26. T.M. Curtis, and C.N. Scholfield Nifedipine blocks Ca2+ store refilling through a pathway not involving L-type Ca2+ channels in rabbit arteriolar smooth muscle J Physiol 532 2001 609 623
27. J.G. De Mey, M.G. Compeer, P. Lemkens, and M.J. Meens ETA-receptor antagonists or allosteric modulators? Trends Pharmacol Sci 32 2011 345 351
28. J.B. Denault, A. Claing, P. Orleans-Juste, T. Sawamura, T. Kido, and T. Masaki Processing of proendothelin-1 by human furin convertase FEBS Lett 362 1995 276 280
29. K.M. Denton, A. Shweta, L. Finkelstein, R.L. Flower, and R.G. Evans Effect of endothelin-1 on regional kidney blood flow and renal arteriole calibre in rabbits Clin Exp Pharmacol Physiol 31 2004 494 501
30. N. Dhaun, C.J. Ferro, A.P. Davenport, W.G. Haynes, J. Goddard, and D.J. Webb Haemodynamic and renal effects of endothelin receptor antagonism in patients with chronic kidney disease Nephrol Dial Transplant 22 2007 3228 3234
31. N. Dhaun, I.M. MacIntyre, D. Kerr, V. Melville, N.R. Johnston, and S. Haughie Selective endothelin-A receptor antagonism reduces proteinuria, blood pressure, and arterial stiffness in chronic proteinuric kidney disease Hypertension 57 2011 772 779
32. F. Dorado, S. Velasco, A. Esparis-Ogando, M. Pericacho, A. Pandiella, and J. Silva The mitogen-activated protein kinase Erk5 mediates human mesangial cell activation Nephrol Dial Transplant 23 2008 3403 3411
33. R.A. Dulce, C. Hurtado, I.L. Ennis, C.D. Garciarena, M.C. Alvarez, and C. Caldiz Endothelin-1 induced hypertrophic effect in neonatal rat cardiomyocytes: involvement of Na+/H+ and Na+/Ca2+ exchangers J Mol Cell Cardiol 41 2006 807 815
34. R.M. Edwards, W. Trizna, and E.H. Ohlstein Renal microvascular effects of endothelin Am J Physiol 259 1990 F217 F221
35. N. Emoto, and M. Yanagisawa Endothelin-converting enzyme-2 is a membrane-bound, phosphoramidon-sensitive metalloprotease with acidic pH optimum J Biol Chem 270 1995 15262 15268
36. N. Emoto, Y. Nurhantari, H. Alimsardjono, J. Xie, T. Yamada, and M. Yanagisawa Constitutive lysosomal targeting and degradation of bovine endothelin-converting enzyme-1a mediated by novel signals in its alternatively spliced cytoplasmic tail J Biol Chem 274 1999 1509 1518
37. M. Endoh Signal transduction and Ca2+ signaling in intact myocardium J Pharmacol Sci 100 2006 525 537
38. N.J. Evans, and J.W. Walker Endothelin receptor dimers evaluated by FRET, ligand binding, and calcium mobilization Biophys J 95 2008 483 492
39. R.G. Evans, A.C. Madden, J.J. Oliver, and T.V. Lewis Effects of ET(A)- and ET(B)-receptor antagonists on regional kidney blood flow, and responses to intravenous endothelin-1, in anaesthetized rabbits J Hypertens 19 2001 1789 1799
40. J. Fareh, R.M. Touyz, E.L. Schiffrin, and G. Thibault Endothelin-1 and angiotensin II receptors in cells from rat hypertrophied heart. Receptor regulation and intracellular Ca2+ modulation Circ Res 78 1996 302 311
41. C. Fligny, M. Barton, and P.L. Tharaux Endothelin and podocyte injury in chronic kidney disease Contrib Nephrol 172 2011 120 138
42. H. Fujisaki, H. Ito, Y. Hirata, M. Tanaka, M. Hata, and M. Lin Natriuretic peptides inhibit angiotensin II-induced proliferation of rat cardiac fibroblasts by blocking endothelin-1 gene expression J Clin Invest 96 1995 1059 1065
43. E. Gagliardini, D. Corna, C. Zoja, F. Sangalli, F. Carrara, and M. Rossi Unlike each drug alone, lisinopril if combined with avosentan promotes regression of renal lesions in experimental diabetes Am J Physiol Renal Physiol 297 2009 F1448 F1456
44. C.E. Gariepy, T. Ohuchi, S.C. Williams, J.A. Richardson, and M. Yanagisawa Salt-sensitive hypertension in endothelin-B receptor-deficient rats J Clin Invest 105 2000 925 933
45. Y. Ge, D. Ahn, P.K. Stricklett, A.K. Hughes, M. Yanagisawa, and J.G. Verbalis Collecting duct-specific knockout of endothelin-1 alters vasopressin regulation of urine osmolality Am J Physiol Renal Physiol 288 2005 F912 F920
46. Y. Ge, P.K. Stricklett, A.K. Hughes, M. Yanagisawa, and D.E. Kohan Collecting duct-specific knockout of the endothelin A receptor alters renal vasopressin responsiveness, but not sodium excretion or blood pressure Am J Physiol Renal Physiol 289 2005 F692 F698
47. Y. Ge, A. Bagnall, P.K. Stricklett, K. Strait, D.J. Webb, and Y. Kotelevtsev Collecting duct-specific knockout of the endothelin B receptor causes hypertension and sodium retention Am J Physiol Renal Physiol 291 2006 F1274 F1280
48. Y. Ge, A. Bagnall, P.K. Stricklett, D. Webb, Y. Kotelevtsev, and D.E. Kohan Combined knockout of collecting duct endothelin A and B receptors causes hypertension and sodium retention Am J Physiol Renal Physiol 295 2008 F1635 F1640
49. J. Goddard, N.R. Johnston, M.F. Hand, A.D. Cumming, T.J. Rabelink, and A.J. Rankin Endothelin-A receptor antagonism reduces blood pressure and increases renal blood flow in hypertensive patients with chronic renal failure: a comparison of selective and combined endothelin receptor blockade Circulation 109 2004 1186 1193
50. S. Goruppi, and J.M. Kyriakis The pro-hypertrophic basic helix-loop-helix protein p8 is degraded by the ubiquitin/proteasome system in a protein kinase B/Akt- and glycogen synthase kinase-3-dependent manner, whereas endothelin induction of p8 mRNA and renal mesangial cell hypertrophy require NFAT4 J Biol Chem 279 2004 20950 20958
51. A.V. Gourine, A.I. Molosh, D. Poputnikov, A. Bulhak, P.O. Sjoquist, and J. Pernow Endothelin-1 exerts a preconditioning-like cardioprotective effect against ischaemia/reperfusion injury via the ET(A) receptor and the mitochondrial K(ATP) channel in the rat in vivo Br J Pharmacol 144 2005 331 337
52. H. Hasegawa, K. Hiki, T. Sawamura, T. Aoyama, Y. Okamoto, and S. Miwa Purification of a novel endothelin-converting enzyme specific for big endothelin-3 FEBS Lett 428 1998 304 308
53. Heiden S, Vignon-Zellweger N, Masuda S, Yagi K, Nakayama K, Yanagisawa M, Emoto N. Anti-TNF-α therapy ameliorates cardiac function in mice with reduced endogenous endothelin-1 and increased afterload. Presented at the Twelfth International Conference on Endothelin, unpublished.
54. A. Hemsen, O. Larsson, and J.M. Lundberg Characteristics of endothelin A and B binding sites and their vascular effects in pig peripheral tissues Eur J Pharmacol 208 1991 313 322
55. M. Herrera, N.J. Hong, P.A. Ortiz, and J.L. Garvin Endothelin-1 inhibits thick ascending limb transport via Akt-stimulated nitric oxide production J Biol Chem 284 2009 1454 1460
56. B. Hocher, C. Thone-Reineke, P. Rohmeiss, F. Schmager, T. Slowinski, and V. Burst Endothelin-1 transgenic mice develop glomerulosclerosis, interstitial fibrosis, and renal cysts but not hypertension J Clin Invest 99 1997 1380 1389
57. B. Hocher, I. George, F. Diekmann, R. Zart, J. Rebstock, and A. Schwarz ETA receptor blockade induces fibrosis of the clipped kidney in two-kidney-one-clip renovascular hypertensive rats J Hypertens 18 2000 1807 1814
58. B. Hocher, A. Schwarz, D. Reinbacher, J. Jacobi, A. Lun, and F. Priem Effects of endothelin receptor antagonists on the progression of diabetic nephropathy Nephron 87 2001 161 169
59. B. Hocher, P. Kalk, T. Slowinski, M. Godes, A. Mach, and S. Herzfeld ETA receptor blockade induces tubular cell proliferation and cyst growth in rats with polycystic kidney disease J Am Soc Nephrol 14 2003 367 376
60. B. Hocher, A. Schwarz, T. Slowinski, S. Bachmann, J. Pfeilschifter, and H.H. Neumayer In-vivo interaction of nitric oxide and endothelin J Hypertens 22 2004 111 119
61. M. Iglarz, C. Binkert, K. Morrison, W. Fischli, J. Gatfield, and A. Treiber Pharmacology of macitentan, an orally active tissue-targeting dual endothelin receptor antagonist J Pharmacol Exp Ther 327 2008 736 745
62. S. Ikeda, N. Emoto, H. Alimsardjono, M. Yokoyama, and M. Matsuo Molecular isolation and characterization of novel four subisoforms of ECE-2 Biochem Biophys Res Commun 293 2002 421 426
63. E.W. Inscho, J.D. Imig, A.K. Cook, and D.M. Pollock ETA and ETB receptors differentially modulate afferent and efferent arteriolar responses to endothelin Br J Pharmacol 146 2005 1019 1026
64. Y. Irukayama-Tomobe, T. Miyauchi, S. Sakai, Y. Kasuya, T. Ogata, and M. Takanashi Endothelin-1-induced cardiac hypertrophy is inhibited by activation of peroxisome proliferator-activated receptor-alpha partly via blockade of c-Jun NH2-terminal kinase pathway Circulation 109 2004 904 910
65. K. Ishikawa, M. Ihara, K. Noguchi, T. Mase, N. Mino, and T. Saeki Biochemical and pharmacological profile of a potent and selective endothelin B-receptor antagonist, BQ-788 Proc Natl Acad Sci U S A 91 1994 4892 4896
66. E. Iwai-Kanai, and K. Hasegawa Intracellular signaling pathways for norepinephrine- and endothelin-1-mediated regulation of myocardial cell apoptosis Mol Cell Biochem 259 2004 163 168
67. H.S. Jae, M. Winn, T.W. von Geldern, B.K. Sorensen, W.J. Chiou, and B. Nguyen Pyrrolidine-3-carboxylic acids as endothelin antagonists. 5. Highly selective, potent, and orally active ET(A) antagonists J Med Chem 44 2001 3978 3984
68. P. Johnstrom, T.D. Fryer, H.K. Richards, N.G. Harris, O. Barret, and J.C. Clark Positron emission tomography using 18F-labelled endothelin-1 reveals prevention of binding to cardiac receptors owing to tissue-specific clearance by ET B receptors in vivo Br J Pharmacol 144 2005 115 122
69. Y. Kakinuma, T. Miyauchi, K. Yuki, N. Murakoshi, K. Goto, and I. Yamaguchi Novel molecular mechanism of increased myocardial endothelin-1 expression in the failing heart involving the transcriptional factor hypoxia-inducible factor-1alpha induced for impaired myocardial energy metabolism Circulation 103 2001 2387 2394
70. P. Kalk, J. Sharkovska, E. Kashina, K. von Websky, K. Relle, and T. Pfab Endothelin-converting enzyme/neutral endopeptidase inhibitor SLV338 prevents hypertensive cardiac remodeling in a blood pressure-independent manner Hypertension 57 2011 755 763
71. P.R. Kalra, J.C. Moon, and A.J. Coats Do results of the ENABLE (Endothelin Antagonist Bosentan for Lowering Cardiac Events in Heart Failure) study spell the end for non-selective endothelin antagonism in heart failure? Int J Cardiol 85 2002 195 197
72. R.M. Kedzierski, P.A. Grayburn, Y.Y. Kisanuki, C.S. Williams, R.E. Hammer, and J.A. Richardson Cardiomyocyte-specific endothelin A receptor knockout mice have normal cardiac function and an unaltered hypertrophic response to angiotensin II and isoproterenol Mol Cell Biol 23 2003 8226 8232
73. Y.Y. Kisanuki, N. Emoto, T. Ohuchi, B. Widyantoro, K. Yagi, and K. Nakayama Low blood pressure in endothelial cell-specific endothelin 1 knockout mice Hypertension 56 2010 121 128
74. D.E. Kohan, E. Padilla, and A.K. Hughes Endothelin B receptor mediates ET-1 effects on cAMP and PGE2 accumulation in rat IMCD Am J Physiol 265 1993 F670 F676
75. D.E. Kohan, Y. Pritchett, M. Molitch, S. Wen, T. Garimella, and P. Audhya Addition of Atrasentan to Renin-Angiotensin System Blockade Reduces Albuminuria in Diabetic Nephropathy J Am Soc Nephrol 22 2011 763 772
76. K. Komukai, J. Uchi, S. Morimoto, M. Kawai, K. Hongo, and M. Yoshimura Role of Ca(2+)/calmodulin-dependent protein kinase II in the regulation of the cardiac L-type Ca(2+) current during endothelin-1 stimulation Am J Physiol Heart Circ Physiol 298 2010 H1902 H1907
77. H.T. Kuo, S.J. Shin, M.C. Kuo, and H.C. Chen Effects of specific endothelin-1 receptor antagonists on proliferation and fibronectin production of glomerular mesangial cells stimulated with Angiotensin II Kaohsiung J Med Sci 22 2006 371 376
78. Y. Kurihara, H. Kurihara, H. Suzuki, T. Kodama, K. Maemura, and R. Nagai Elevated blood pressure and craniofacial abnormalities in mice deficient in endothelin-1 Nature 368 1994 703 710
79. K. Laghmani, P.A. Preisig, O.W. Moe, M. Yanagisawa, and R.J. Alpern Endothelin-1/endothelin-B receptor-mediated increases in NHE3 activity in chronic metabolic acidosis J Clin Invest 107 2001 1563 1569
80. Y. Liu, J. Yang, H. Ren, D. He, A. Pascua, and M.I. Armando Inhibitory effect of ETB receptor on Na(+)-K(+) ATPase activity by extracellular Ca(2+) entry and Ca(2+) release from the endoplasmic reticulum in renal proximal tubule cells Hypertens Res 32 2009 846 852
81. L. Liu, M. Zacchia, X. Tian, L. Wan, A. Sakamoto, and M. anagisawa Acid regulation of NaDC-1 requires a functional endothelin B receptor Kidney Int 78 2010 895 904
82. P.A. MacCarthy, R. Grocott-Mason, B.D. Prendergast, and A.M. Shah Contrasting inotropic effects of endogenous endothelin in the normal and failing human heart: studies with an intracoronary ET(A) receptor antagonist Circulation 101 2000 142 147
83. E.E. MacNulty, R. Plevin, and M.J. Wakelam Stimulation of the hydrolysis of phosphatidylinositol 4,5-bisphosphate and phosphatidylcholine by endothelin, a complete mitogen for Rat-1 fibroblasts Biochem J 272 1990 761 766
84. J.F. Mann, D. Green, K. Jamerson, L.M. Ruilope, S.J. Kuranoff, and T. Littke Avosentan for overt diabetic nephropathy J Am Soc Nephrol 21 2010 527 535
85. A.K. Marshall, O.P. Barrett, T.E. Cullingford, A. Shanmugasundram, P.H. Sugden, and A. Clerk ERK1/2 signaling dominates over RhoA signaling in regulating early changes in RNA expression induced by endothelin-1 in neonatal rat cardiomyocytes PLoS One 5 2010 e10027
86. H. Matsumoto, N. Suzuki, H. Onda, and M. Fujino Abundance of endothelin-3 in rat intestine, pituitary gland and brain Biochem Biophys Res Commun 164 1989 74 80
87. T. Matsuura, K. Miura, T. Ebara, T. Yukimura, S. Yamanaka, and S. Kim Renal vascular effects of the selective endothelin receptor antagonists in anaesthetized rats Br J Pharmacol 122 1997 81 86
88. L. Mcmurdo, C. Thiermermann, and J.R. Vane The endothelin ETB receptor agonist, IRL 1620, causes vasodilation and inhibits ex vivo platelet aggregation in the anaesthetised rabbit Eur J Pharmacol 259 1994 51 55
89. R. Mishra, Y. Wang, and M.S. Simonson Cell cycle signaling by endothelin-1 requires Src nonreceptor protein tyrosine kinase Mol Pharmacol 67 2005 2049 2056
90. K. Miyagawa, N. Emoto, B. Widyantoro, K. Nakayama, K. Yagi, and Y. Rikitake Attenuation of Doxorubicin-induced cardiomyopathy by endothelin-converting enzyme-1 ablation through prevention of mitochondrial biogenesis impairment Hypertension 55 2010 738 746
91. K. Moridaira, M. Nodera, G. Sato, and H. Yanagisawa Detection of prepro-ET-1 mRNA in normal rat kidney by in situ RT-PCR Nephron Exp Nephrol 95 2003 e55 e61
92. M. Morigi, S. Buelli, S. Angioletti, C. Zanchi, L. Longaretti, and C. Zoja In response to protein load podocytes reorganize cytoskeleton and modulate endothelin-1 gene: implication for permselective dysfunction of chronic nephropathies Am J Pathol 166 2005 1309 1320
93. S. Motte, K. McEntee, and R. Naeije Endothelin receptor antagonists Pharmacol Ther 110 2006 386 414
94. P. Mylona, and J.G. Cleland Update of REACH-1 and MERIT-HF clinical trials in heart failure. Cardio.net Editorial Team Eur J Heart Fail 1 1999 197 200
95. N. Mzhavia, H. Pan, F.Y. Che, L.D. Fricker, and L.A. Devi Characterization of endothelin-converting enzyme-2. Implication for a role in the nonclassical processing of regulatory peptides J Biol Chem 278 2003 14704 14711
96. N. Nagata, Y. Niwa, and Y. Nakaya A novel 31-amino-acid-length endothelin, ET-1(1-31), can act as a biologically active peptide for vascular smooth muscle cells Biochem Biophys Res Commun 275 2000 595 600
97. D. Nakano, and D.M. Pollock Contribution of endothelin A receptors in endothelin 1-dependent natriuresis in female rats Hypertension 53 2009 324 330
98. I. Namekata, S. Fujiki, Y. Kawakami, R. Moriwaki, K. Takeda, and T. Kawanishi Intracellular mechanisms and receptor types for endothelin-1-induced positive and negative inotropy in mouse ventricular myocardium Naunyn Schmiedebergs Arch Pharmacol 376 2008 385 395
99. K. Nishimaru, Y. Miura, and M. Endoh Mechanisms of endothelin-1-induced decrease in contractility in adult mouse ventricular myocytes Br J Pharmacol 152 4 2007 456 463 [Oct]
100. C.M. O'Connor, W.A. Gattis, AKJ, V. Hasselblad, B. Chandler, and A. Frey Randomized Intravenous TeZosentan Study-4 Investigators. Tezosentan in patients with acute heart failure and acute coronary syndromes: results of the Randomized Intravenous TeZosentan Study (RITZ-4) J Am Coll Cardiol 41 2003 1452 1457
101. T.J. Opgenorth, J.L. Wessale, D.B. Dixon, A.L. Adler, S.V. Calzadilla, and R.J. Padley Effects of endothelin receptor antagonists on the plasma immunoreactive endothelin-1 level J Cardiovasc Pharmacol 36 2000 S292 S296
102. P. Orleans-Juste, M. Plante, J.C. Honore, E. Carrier, and J. Labonte Synthesis and degradation of endothelin-1 Can J Physiol Pharmacol 81 2003 503 510
103. J. Ortmann, K. Amann, R.P. Brandes, M. Kretzler, K. Munter, and N. Parekh Role of podocytes for reversal of glomerulosclerosis and proteinuria in the aging kidney after endothelin inhibition Hypertension 44 2004 974 981
104. A. Owada, K. Tomita, Y. Terada, H. Sakamoto, H. Nonoguchi, and F. Marumo Endothelin (ET)-3 stimulates cyclic guanosine 3′,5′-monophosphate production via ETB receptor by producing nitric oxide in isolated rat glomerulus, and in cultured rat mesangial cells J Clin Invest 93 1994 556 563
105. T.L. Pallone, and E.P. Silldorff Pericyte regulation of renal medullary blood flow Exp Nephrol 9 2001 165 170
106. T.S. Pavlov, A. Chahdi, D.V. Ilatovskaya, V. Levchenko, A. Vandewalle, and O. Pochynyuk Endothelin-1 inhibits the epithelial Na+ channel through betaPix/14-3-3/Nedd4-2 J Am Soc Nephrol 21 2010 833 843
107. J. Pernow, and A. Modin Endothelial regulation of coronary vascular tone in vitro: contribution of endothelin receptor subtypes and nitric oxide Eur J Pharmacol 243 1993 281 286
108. T. Pfab, C. Thone-Reineke, F. Theilig, I. Lange, H. Witt, and C. Maser-Gluth Diabetic endothelin B receptor-deficient rats develop severe hypertension and progressive renal failure J Am Soc Nephrol 17 2006 1082 1089
109. J. Piuhola, M. Makinen, I. Szokodi, and H. Ruskoaho Dual role of endothelin-1 via ETA and ETB receptors in regulation of cardiac contractile function in mice Am J Physiol Heart Circ Physiol 285 2003 H112 H118
110. J. Piuhola, I. Szokodi, P. Kinnunen, M. Ilves, R. Dechatel, and O. Vuolteenaho Endothelin-1 contributes to the Frank-Starling response in hypertrophic rat hearts Hypertension 41 2003 93 98
111. C.F. Plato, D.M. Pollock, and J.L. Garvin Endothelin inhibits thick ascending limb chloride flux via ET(B) receptor-mediated NO release Am J Physiol Renal Physiol 279 2000 F326 F333
112. S. Prié, D.J. Stewart, and J. Dupuis EndothelinA receptor blockade improves nitric oxide-mediated vasodilation in monocrotaline-induced pulmonary hypertension Circulation 97 1998 2169 2174
113. C. Qiu, L. Samsell, and C. Baylis Actions of endogenous endothelin on glomerular hemodynamics in the rat Am J Physiol 269 1995 R469 R473
114. T. Quaschning, B. Rebhan, C. Wunderlich, C. Wanner, C.M. Richter, and T. Pfab Endothelin B receptor-deficient mice develop endothelial dysfunction independently of salt loading J Hypertens 23 2005 979 985
115. I. Rubinstein, K. Gurbanov, A. Hoffman, O.S. Better, and J. Winaver Differential effect of endothelin-1 on renal regional blood flow: role of nitric oxide J Cardiovasc Pharmacol 26 Suppl. 3 1995 S208 S210
116. H. Ruetten, and C. Thiemermann Endothelin-1 stimulates the biosynthesis of tumour necrosis factor in macrophages: ET-receptors, signal transduction and inhibition by dexamethasone J Physiol Pharmacol 48 1997 675 688
117. V.A. Rufanova, A. Alexanian, T. Wakatsuki, A. Lerner, and A. Sorokin Pyk2 mediates endothelin-1 signaling via p130Cas/BCAR3 cascade and regulates human glomerular mesangial cell adhesion and spreading J Cell Physiol 219 2009 45 56
118. N. Ruiz-Opazo, K. Hirayama, K. Akimoto, and V.L. Herrera Molecular characterization of a dual endothelin-1/angiotensin II receptor Mol Med 4 1998 96 108
119. K. Saida, N. Kometani, T. Uchide, and Y. Mitsui Sequence analysis and expression of the mouse full-length vasoactive intestinal contractor/endothelin- 2 gene (EDN2): comparison with the endothelin-1 gene (EDN1) Clin Sci (Lond) 103 Suppl. 48 2002 84S 89S
120. S. Sakai, T. Miyauchi, M. Kobayashi, I. Yamaguchi, K. Goto, and Y. Sugishita Inhibition of myocardial endothelin pathway improves long-term survival in heart failure Nature 384 1996 353 355
121. S. Sakai, T. Miyauchi, and I. Yamaguchi Long-term endothelin receptor antagonist administration improves alterations in expression of various cardiac genes in failing myocardium of rats with heart failure Circulation 101 2000 2849 2853
122. T. Sakurai, M. Yanagisawa, Y. Takuwa, H. Miyazaki, S. Kimura, and K. Goto Cloning of a cDNA encoding a non-isopeptide-selective subtype of the endothelin receptor Nature 348 1990 732 735
123. M.A. Saleh, E.I. Boesen, J.S. Pollock, V.J. Savin, and D.M. Pollock Endothelin-1 increases glomerular permeability and inflammation independent of blood pressure in the rat Hypertension 56 2010 942 949
124. M.A. Saleh, J.S. Pollock, and D.M. Pollock Distinct actions of endothelin A-selective versus combined endothelin A/B receptor antagonists in early diabetic kidney disease J Pharmacol Exp Ther 338 2011 263 270
125. S. Sauvageau, E. Thorin, L. Villeneuve, and J. Dupuis Change in pharmacological effect of endothelin receptor antagonists in rats with pulmonary hypertension: role of ETB-receptor expression levels Pulm Pharmacol Ther 22 4 2009 311 317 [Aug]
126. J. Schildroth, J. Rettig-Zimmermann, P. Kalk, A. Steege, M. Fahling, and M. Sendeski Endothelin type A and B receptors in the control of afferent and efferent arterioles in mice Nephrol Dial Transplant 26 2011 779 789
127. M.P. Schneider, E.W. Inscho, and D.M. Pollock Attenuated vasoconstrictor responses to endothelin in afferent arterioles during a high-salt diet Am J Physiol Renal Physiol 292 2007 F1208 F1214
128. M.P. Schneider, Y. Ge, D.M. Pollock, J.S. Pollock, and D.E. Kohan Collecting duct-derived endothelin regulates arterial pressure and Na excretion via nitric oxide Hypertension 51 2008 1605 1610
129. N. Shimojo, S. Jesmin, S. Zaedi, S. Maeda, M. Soma, and K. Aonuma Eicosapentaenoic acid prevents endothelin-1-induced cardiomyocyte hypertrophy in vitro through the suppression of TGF-beta 1 and phosphorylated JNK Am J Physiol Heart Circ Physiol 291 2006 H835 H845
130. N. Shimojo, S. Jesmin, S. Zaedi, T. Otsuki, S. Maeda, and N. Yamaguchi Contributory role of VEGF overexpression in endothelin-1-induced cardiomyocyte hypertrophy Am J Physiol Heart Circ Physiol 293 2007 H474 H481
131. H.E. Shubeita, P.M. McDonough, A.N. Harris, K.U. Knowlton, C.C. Glembotski, and J.H. Brown Endothelin induction of inositol phospholipid hydrolysis, sarcomere assembly, and cardiac gene expression in ventricular myocytes. A paracrine mechanism for myocardial cell hypertrophy J Biol Chem 265 1990 20555 20562
132. M.S. Simonson, and M.J. Dunn Cellular signaling by peptides of the endothelin gene family FASEB J 4 1990 2989 3000
133. X. Song, V. Di Giovanni, N. He, K. Wang, A. Ingram, and N.D. Rosenblum Systems biology of autosomal dominant polycystic kidney disease (ADPKD): computational identification of gene expression pathways and integrated regulatory networks Hum Mol Genet 18 2009 2328 2343
134. L.R. Stow, M.E. Jacobs, C.S. Wingo, and B.D. Cain Endothelin-1 gene regulation FASEB J 25 2011 16 28
135. F.E. Strachan, J.C. Spratt, I.B. Wilkinson, N.R. Johnston, G.A. Gray, and D.J. Webb Systemic blockade of the endothelin-B receptor increases peripheral vascular resistance in healthy men Hypertension 33 1999 581 585
136. K.A. Strait, P.K. Stricklett, and D.E. Kohan Altered collecting duct adenylyl cyclase content in collecting duct endothelin-1 knockout mice BMC Nephrol 8 2007 8
137. P.K. Stricklett, A.K. Hughes, and D.E. Kohan Endothelin-1 stimulates NO production and inhibits cAMP accumulation in rat inner medullary collecting duct through independent pathways Am J Physiol Renal Physiol 290 2006 F1315 F1319
138. J.C. Sullivan, T.T. Goodchild, Z. Cai, D.M. Pollock, and J.S. Pollock Endothelin(A) (ET(A)) and ET(B) receptor-mediated regulation of nitric oxide synthase 1 (NOS1) and NOS3 isoforms in the renal inner medulla Acta Physiol (Oxf) 191 2007 329 336
139. T. Suzuki, and T. Miyauchi A novel pharmacological action of ET-1 to prevent the cytotoxicity of doxorubicin in cardiomyocytes Am J Physiol Regul Integr Comp Physiol 280 2001 R1399 R1406
140. Y. Suzuki, O. Lopez-Franco, D. Gomez-Garre, N. Tejera, C. Gomez-Guerrero, and T. Sugaya Renal tubulointerstitial damage caused by persistent proteinuria is attenuated in AT1-deficient mice: role of endothelin-1 Am J Pathol 159 2001 1895 1904
141. A. Tahara, J. Tsukada, Y. Tomura, T. Suzuki, T. Yatsu, and M. Shibasaki Vasopressin stimulates the production of extracellular matrix by cultured rat mesangial cells Clin Exp Pharmacol Physiol 35 2008 586 593
142. M.A. Talukder, I. Norota, K. Sakurai, and M. Endoh Inotropic response of rabbit ventricular myocytes to endothelin-1: difference from isolated papillary muscles Am J Physiol Heart Circ Physiol 281 2001 H596 H605
143. T.A. Taylor, C.E. Gariepy, D.M. Pollock, and J.S. Pollock Gender differences in ET and NOS systems in ETB receptor-deficient rats: effect of a high salt diet Hypertension 41 2003 657 662
144. C. Thöne-Reineke, K. SImon, C.M. Richter, M. Godes, H.H. Neumayer, and D. Thormahlen Inhibition of both neutral endopeptidase and endothelin-converting enzyme by SLV306 reduces proteinuria and urinary albumin excretion in diabetic rats J Cardiovasc Pharmacol 44 2004 S76 S79
145. C.R. Tirapelli, D.A. Casolari, A. Yogi, A.C. Montezano, R.C. Tostes, and E. Legros Functional characterization and expression of endothelin receptors in rat carotid artery: involvement of nitric oxide, a vasodilator prostanoid and the opening of K+ channels in ETB-induced relaxation Br J Pharmacol 146 2005 903 912
146. H. Tsukahara, H. Ende, H.I. Magazine, W.F. Bahou, and M.S. Goligorsky Molecular and functional characterization of the non-isopeptide-selective ETB receptor in endothelial cells. Receptor coupling to nitric oxide synthase J Biol Chem 269 1994 21778 21785
147. M.C. Verhaar, F.E. Strachan, D.E. Newby, N.L. Cruden, H.A. Koomans, and T.J. Rabelink Endothelin-A receptor antagonist-mediated vasodilatation is attenuated by inhibition of nitric oxide synthesis and by endothelin-B receptor blockade Circulation 97 1998 752 756
148. N. Vignon-Zellweger, K. Relle, E. Kienlen, M. Alter, P. Seider, and J. Sharkovska Endothelin-1 overexpression restores diastolic function in eNOS knockout mice J Hypertens 29 2011 961 970
149. J.L. Vuurmans, P. Boer, and H.A. Koomans Effects of endothelin-1 and endothelin-1-receptor blockade on renal function in humans Nephrol Dial Transplant 19 2004 2742 2746
150. O.F. Wagner, G. Christ, J. Wojta, H. Vierhapper, S. Parzer, and P.J. Nowotny Polar secretion of endothelin-1 by cultured endothelial cells J Biol Chem 267 1992 16066 16068
151. M.H. Wang, A. Fok, M.H. Huang, and N.L. Wong Interaction between endothelin and angiotensin II in the up-regulation of vasopressin messenger RNA in the inner medullary collecting duct of the rat Metabolism 56 2007 1372 1376
152. A.M. Watson, J. Li, C. Schumacher, de GM, B. Feng, and M.C. Thomas The endothelin receptor antagonist avosentan ameliorates nephropathy and atherosclerosis in diabetic apolipoprotein E knockout mice Diabetologia 53 2010 192 203
153. S.W. Watts Endothelin receptors: what's new and what do we need to know? Am J Physiol Regul Integr Comp Physiol 298 2010 R254 R260
154. M. Wendel, L. Knels, W. Kummer, and T. Koch Distribution of endothelin receptor subtypes ETA and ETB in the rat kidney J Histochem Cytochem 54 2006 1193 1203
155. R.R. Wenzel, T. Littke, S. Kuranoff, C. Jürgens, H. Bruck, and E. Ritz PP301 (Avosentan) Endothelin Antagonist Evaluation in Diabetic Nephropathy Study Investigators: Avosentan reduces albumin excretion in diabetics with macroalbuminuria J Am Soc Nephrol 20 2009 655 664
156. B. Widyantoro, N. Emoto, K. Nakayama, D.W. Anggrahini, S. Adiarto, and N. Iwasa Endothelial cell-derived endothelin-1 promotes cardiac fibrosis in diabetic hearts through stimulation of endothelial-to-mesenchymal transition Circulation 121 2010 2407 2418
157. N.L. Wong, B.P. Wong, and J.K. Tsui Vasopressin regulates endothelin-B receptor in rat inner medullary collecting duct Am J Physiol Renal Physiol 278 2000 F369 F374
158. N.L. Wong, M. Sonntag, and J.K. Tsui Attenuation of renal vasopressin V2 receptor upregulation by bosentan, an ETA/ETB receptor antagonist Metabolism 52 2003 1141 1146
159. D. Xu, N. Emoto, A. Giaid, C. Slaughter, S. Kaw, and D. deWit ECE-1: a membrane-bound metalloprotease that catalyzes the proteolytic activation of big endothelin-1 Cell 78 1994 473 485
160. T. Yamamoto, T. Hirohama, and H. Uemura Endothelin B receptor-like immunoreactivity in podocytes of the rat kidney Arch Histol Cytol 65 2002 245 250
161. T. Yamamoto, H. Suzuki, Y. Kubo, A. Matsumoto, and H. Uemura Endothelin A receptor-like immunoreactivity on the basal infoldings of rat renal tubules and collecting ducts Arch Histol Cytol 71 2008 77 87
162. M. Yanagisawa, H. Kurihara, S. Kimura, Y. Tomobe, M. Kobayashi, and Y. Mitsui A novel potent vasoconstrictor peptide produced by vascular endothelial cells Nature 332 1988 411 415
163. M.L. Zeidel, H.R. Brady, B.C. Kone, S.R. Gullans, and B.M. Brenner Endothelin, a peptide inhibitor of Na(+)-K(+)-ATPase in intact renaltubular epithelial cells Am J Physiol 257 1989 C1101 C1107
164. C. Zeng, L.D. Asico, C. Yu, V.A. Villar, W. Shi, and Y. Luo Renal D3 dopamine receptor stimulation induces natriuresis by endothelin B receptor interactions Kidney Int 74 2008 750 759
165. Q. Zeng, Q. Zhou, F. Yao, S.T. O'Rourke, and C. Sun Endothelin-1 regulates cardiac L-type calcium channels via NAD(P)H oxidase-derived superoxide J Pharmacol Exp Ther 326 2008 732 738
166. W. Zhang, H. Meng, Z.H. Li, Z. Shu, X. Ma, and B.X. Zhang Regulation of STIM1, store-operated Ca2+ influx, and nitric oxide generation by retinoic acid in rat mesangial cells Am J Physiol Renal Physiol 292 2007 F1054 F1064
167. X.S. Zhao, W. Pan, R. Bekeredjian, and R.V. Shohet Endogenous endothelin-1 is required for cardiomyocyte survival in vivo Circulation 114 2006 830 837